Ekaterina Lyutsova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ekaterina Lyutsova has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Diana Radkova
Medical University of Varna
2 shared publicationsKalina Pavlova
Medical University of Varna
2 shared publicationsIliyan Lyutsov
St. Anna Hospital, Varna
1 shared publicationMargarita Gospodinova
Medical University of Varna
1 shared publication- Margarita Gospodinova
Department of Infectious Diseases, Parasitology and Dermatovenerology, Faculty of Medicine, Medical University of Varna, 9002 Varna, Bulgaria
1 shared publication Margarita Gospodinova-Bliznakova
Medical University of Varna
1 shared publication
Latest Publications
- Open Access
- 8 December 2024
- Published by Medical University Prof. Dr. Paraskev Stoyanov - Varna in Scripta Scientifica Medica
- Vol. 56 (4) , 15-23
The integration of artificial intelligence in malaria control and surveillance
The integration of artificial intelligence in malaria control and surveillance
- 8 December 2024
- Published by Medical University Prof. Dr. Paraskev Stoyanov - Varna in Scripta Scientifica Medica
- Vol. 56 (4) , 15-23
Open AccessThe integration of artificial intelligence in malaria control and surveillance
The integration of artificial intelligence in malaria control and surveillance
- Open Access
- 16 April 2023
- Published by Medical University Prof. Dr. Paraskev Stoyanov - Varna in Scripta Scientifica Medica
- Vol. 55 (1) , 19-26
Clinical Analysis of Pregnant Women with COVID-19 in Bulgaria
Clinical Analysis of Pregnant Women with COVID-19 in Bulgaria
- 16 April 2023
- Published by Medical University Prof. Dr. Paraskev Stoyanov - Varna in Scripta Scientifica Medica
- Vol. 55 (1) , 19-26
Open AccessClinical Analysis of Pregnant Women with COVID-19 in Bulgaria
Clinical Analysis of Pregnant Women with COVID-19 in Bulgaria
- Open Access
- 13 May 2022
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 12 (2) , 366-372
The epidemiological and clinical study of patients with clostridium difficile enterocolitis in Varna, Bulgaria
Introduction. Clostridium difficile infections (CDI) remain a global health concern. Currently, no unified approach to the diagnostics and determining severity of these infections despite their high urgency throughout the world was proposed. The aim of the study is to identify risk factors for CDI, investigate clinical and epidemiological features of the disease course and potential for using the ATLAS scale to assess its severity. Materials and methods. 36 CDI patients hospitalized at the Infectious Disease Clinic of Varna were analyzed during the period from January 2018 until June 2019. Clinical and epidemiologic study was conducted. The diagnosis was made by using a rapid immunochromatographic test; CDI patient stratification was performed by ATLAS scoring system. Results and discussion. Within the aforementioned period, 1100 patients were hospitalized at the Infectious Disease Clinic of Varna, and CDIs were reported in 3,3% of cases. The most affected were elderly individuals (the mean age was 69,816,4 years old) most of whom were females (92%) with only 6% of males. The following risk factors were investigated: comorbidities 32 patients (88,89%), recent hospitalization 19 patients (52,78%), antibiotic use 31 patients (86,11%). Twenty-four patients (66,67%, ATLAS score 4 points) had mild CDI, whereas moderate form of CDI was observed in 12 patients (33,33%). No severe CDI or death were observed. The characteristic clinical presentation included fever, diarrhea and abdominal cramping. The treatment was implemented according to the national and international recommendations by using oral Metronidazole for 11 patients (30,56%), Vancomycin for 12 patients (33,33%), or both for 13 patients (36,11%). Conclusion. Patients at risk with symptoms of enterocolitis and a history of antibiotic use or hospitalizations should be screened for the presence of toxin-forming strains of Clostridium difficile. According to the European Centre for Disease Prevention (ECDC) the diagnostic yield of CDI may be increased by using two-step protocol, whereas the ATLAS score system may be a useful tool for routine evaluation of patients with CDI.
- 13 May 2022
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 12 (2) , 366-372
Open AccessThe epidemiological and clinical study of patients with clostridium difficile enterocolitis in Varna, Bulgaria
Introduction. Clostridium difficile infections (CDI) remain a global health concern. Currently, no unified approach to the diagnostics and determining severity of these infections despite their high urgency throughout the world was proposed. The aim of the study is to identify risk factors for CDI, investigate clinical and epidemiological features of the disease course and potential for using the ATLAS scale to assess its severity. Materials and methods. 36 CDI patients hospitalized at the Infectious Disease Clinic of Varna were analyzed during the period from January 2018 until June 2019. Clinical and epidemiologic study was conducted. The diagnosis was made by using a rapid immunochromatographic test; CDI patient stratification was performed by ATLAS scoring system. Results and discussion. Within the aforementioned period, 1100 patients were hospitalized at the Infectious Disease Clinic of Varna, and CDIs were reported in 3,3% of cases. The most affected were elderly individuals (the mean age was 69,816,4 years old) most of whom were females (92%) with only 6% of males. The following risk factors were investigated: comorbidities 32 patients (88,89%), recent hospitalization 19 patients (52,78%), antibiotic use 31 patients (86,11%). Twenty-four patients (66,67%, ATLAS score 4 points) had mild CDI, whereas moderate form of CDI was observed in 12 patients (33,33%). No severe CDI or death were observed. The characteristic clinical presentation included fever, diarrhea and abdominal cramping. The treatment was implemented according to the national and international recommendations by using oral Metronidazole for 11 patients (30,56%), Vancomycin for 12 patients (33,33%), or both for 13 patients (36,11%). Conclusion. Patients at risk with symptoms of enterocolitis and a history of antibiotic use or hospitalizations should be screened for the presence of toxin-forming strains of Clostridium difficile. According to the European Centre for Disease Prevention (ECDC) the diagnostic yield of CDI may be increased by using two-step protocol, whereas the ATLAS score system may be a useful tool for routine evaluation of patients with CDI.
- Open Access
- 7 June 2021
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 66 (6) , 371-373
Functions and potential of lipocalin-2 as fecal biomarker for acute gastrointestinal infections (review of literature)
Despite the visible progress in reducing morbidity and mortality from intestinal infections and acute diarrhea associated with them, especially in childhood, the problem of their diagnosis and treatment remains relevant. The article discusses the structure, function and application of lipocalin-2 in infectious diseases as a non-invasive biomarker of bacterial inflammation in the intestine.
- 7 June 2021
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 66 (6) , 371-373
Open AccessFunctions and potential of lipocalin-2 as fecal biomarker for acute gastrointestinal infections (review of literature)
Despite the visible progress in reducing morbidity and mortality from intestinal infections and acute diarrhea associated with them, especially in childhood, the problem of their diagnosis and treatment remains relevant. The article discusses the structure, function and application of lipocalin-2 in infectious diseases as a non-invasive biomarker of bacterial inflammation in the intestine.